Onglyza (on-GLY-zah), the second "gliptin" for type 2 diabetes

September 2009

Reps will be promoting Onglyza (on-GLY-zah), the second "gliptin" for type 2 diabetes.

Think of it as similar to Januvia.

Onglyza (saxagliptin) and Januvia (sitagliptin) are incretin enhancers. They prolong the action of endogenous incretin hormones by blocking their breakdown by the enzyme, dipeptidyl peptidase-4 (DPP-4). This leads to more insulin release after eating.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Cardiology triple antithrombotic therapy with warfarin, aspirin, AND clopidogrel (Plavix)
Gout changes in how colchicine is dosed for acute gout
Respiratory Allergy how fast their inhalers expire once they are unwrapped
Respiratory Allergy whether EpiPen and Twinject needles are long enough to give epinephrine IM
Diabetes Onglyza (on-GLY-zah), the second "gliptin" for type 2 diabetes
Gastroenterology rebound acid-related symptoms after stopping proton pump inhibitors (PPIs)
Lice new Rx treatment for head lice called Ulesfia (yoo-LESS-fee-ah), or benzyl alcohol lotion
Geriatrics What's the best way to treat insomnia in the elderly
Cardiology how to prevent or treat orthostatic hypotension
Probiotics A growing number of products with probiotics
Influenza the safety of H1N1 (swine) flu vaccine
Neurology Pain Is it okay for patients to take ketorolac (Toradol, etc) for more than 5 days

Onglyza (on-GLY-zah), the second "gliptin" for type 2 diabetes

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents